{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:15:29Z","timestamp":1789391729718,"version":"build-2803163510"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Candidiasis is a major fungal infection worldwide, with invasive forms linked to high morbidity and mortality. The emergence of azole resistance in Candida parapsilosis causing candidemia led us to examine the epidemiology and antifungal susceptibility of Candida species at the University Hospital of Li\u00e8ge between January 2017 and December 2023. A total of 916 isolates from blood or sterile body fluids, tissues, and abscesses were analyzed. Species identification was performed using MALDI-TOF MS and antifungal susceptibility testing via Sensititre YO10 AST was interpreted according to the CLSI guidelines. Candida albicans remained the predominant species (56%), followed by Nakaseomyces glabratus (19%), Candida parapsilosis (8%), and Candida tropicalis (7%). No significant shift toward non-albicans Candida species (NAC) was observed even during the COVID-19 pandemic, supporting the use of narrow-spectrum empirical therapy in selected patients. Fluconazole susceptibility was high in C. albicans (98.8%), whereas N. glabratus and C. tropicalis showed high resistance rates with 10.1% and 16.9%, respectively. C. parapsilosis showed stable fluconazole susceptibility across the study period. Echinocandins demonstrated excellent activity (95.6\u2013100%), and amphotericin B was effective against nearly all isolates. This seven-year surveillance at the University Hospital of Li\u00e8ge confirms that while C. albicans remains the predominant and highly susceptible species, rising azole resistance in non-albicans Candida\u2014particularly N. glabratus and C. tropicalis\u2014highlights the critical need for ongoing local epidemiological monitoring to guide effective and targeted antifungal therapy.<\/jats:p>","DOI":"10.3390\/jof11060465","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:11:07Z","timestamp":1750313467000},"page":"465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Species Distribution and Antifungal Susceptibility Patterns of Invasive Candidiasis in a Belgian Tertiary Center: A 7-Year Retrospective Analysis"],"prefix":"10.3390","volume":"11","author":[{"given":"Sarah","family":"Cugnata","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, University Hospital of Liege, 4000 Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-324X","authenticated-orcid":false,"given":"Rosalie","family":"Sacheli","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Center for Interdisciplinary Research on Medicines (CIRM), University Hospital of Liege, 4000 Liege, Belgium"},{"name":"National Reference Center for Mycosis, University Hospital of Liege, 4000 Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-4917","authenticated-orcid":false,"given":"Nathalie","family":"Layios","sequence":"additional","affiliation":[{"name":"Intensive Care Department, University Hospital of Liege, 4000 Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-6493","authenticated-orcid":false,"given":"Marie-Pierre","family":"Hayette","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Center for Interdisciplinary Research on Medicines (CIRM), University Hospital of Liege, 4000 Liege, Belgium"},{"name":"National Reference Center for Mycosis, University Hospital of Liege, 4000 Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global Incidence and Mortality of Severe Fungal Disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11046-024-00871-0","article-title":"Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV","volume":"189","author":"Wolfgruber","year":"2024","journal-title":"Mycopathologia"},{"key":"ref_3","unstructured":"(2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization. [1st ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 Consensus Definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive Candidiasis: Current Clinical Challenges and Unmet Needs in Adult Populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMc1514201","article-title":"Invasive Candidiasis","volume":"374","author":"Kullberg","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Risum, M., Astvad, K., Johansen, H.K., Sch\u00f8nheyder, H.C., Rosenvinge, F., Knudsen, J.D., Hare, R.K., Datcu, R., R\u00f8der, B.L., and Antsupova, V.S. (2021). Update 2016\u20132018 of the Nationwide Danish Fungaemia Surveillance Study: Epidemiologic Changes in a 15-Year Perspective. J. Fungi, 7.","DOI":"10.3390\/jof7060491"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Escribano, P., and Guinea, J. (2022). Fluconazole-Resistant Candida Parapsilosis: A New Emerging Threat in the Fungi Arena. Front. Fungal Biol., 3.","DOI":"10.3389\/ffunb.2022.1010782"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","article-title":"Worldwide Emergence of Fluconazole-Resistant Candida Parapsilosis: Current Framework and Future Research Roadmap","volume":"4","author":"Daneshnia","year":"2023","journal-title":"Lancet Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive Candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997\u20132016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ofab471","DOI":"10.1093\/ofid\/ofab471","article-title":"Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey","volume":"8","author":"Adam","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Franconi, I., Rizzato, C., Tavanti, A., Falcone, M., and Lupetti, A. (2023). Paradigm Shift: Candida Parapsilosis Sensu Stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015\u20132022 Survey. J. Fungi, 9.","DOI":"10.3390\/jof9101012"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"dlaf051","DOI":"10.1093\/jacamr\/dlaf051","article-title":"The S862C Amino Acid Change in CpMrr1 Confers Fluconazole Resistance in Candida Parapsilosis","volume":"7","author":"Franconi","year":"2025","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chowdhary, A., Sharma, C., and Meis, J.F. (2017). Candida Auris: A Rapidly Emerging Cause of Hospital-Acquired Multidrug-Resistant Fungal Infections Globally. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006290"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","unstructured":"(2022). Performance Standards for Antifungal Susceptibility Testing of Yeasts (Standard No. CLSI M27M44S)."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global Guideline for the Diagnosis and Management of Candidiasis: An Initiative of the ECMM in Cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Parslow, B.Y., and Thornton, C.R. (2022). Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10061208"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11046-017-0155-3","article-title":"Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years","volume":"182","author":"Piccinelli","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive Candidiasis as a Cause of Sepsis in the Critically Ill Patient","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the Epidemiological Landscape of Invasive Candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_23","first-page":"1103","article-title":"Changing Epidemiology of Candidaemia in Australia","volume":"72","author":"Chapman","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European Candidaemia Is Characterised by Notable Differential Epidemiology and Susceptibility Pattern: Results from the ECMM Candida III Study","volume":"87","author":"Arendrup","year":"2023","journal-title":"J. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of Candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-Two Years of Candidaemia Surveillance: Results from a Norwegian National Study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/myc.12714","article-title":"Increasing Candidaemia Incidence from 2004 to 2015 with a Shift in Epidemiology in Patients Preexposed to Antifungals","volume":"61","author":"Goemaere","year":"2018","journal-title":"Mycoses"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and Reporting of Candidaemia in Belgium: A Multi-Centre Study","volume":"36","author":"Blot","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.01998-13","article-title":"Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain","volume":"51","author":"Bassetti","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.2147\/IDR.S274872","article-title":"Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches","volume":"14","author":"Tortorano","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CLEP.S459600","article-title":"Epidemiology of Invasive Candidiasis","volume":"16","author":"Bays","year":"2024","journal-title":"Clin. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e02098-21","DOI":"10.1128\/aac.02098-21","article-title":"Azole-Resistant Alleles of ERG11 in Candida Glabrata Trigger Activation of the Pdr1 and Upc2A Transcription Factors","volume":"66","author":"Vu","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clinmicnews.2014.08.001","article-title":"Current Epidemiology of Candida Infection","volume":"36","author":"Lockhart","year":"2014","journal-title":"Clin. Microbiol. Newsl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jmii.2013.08.017","article-title":"Changing Epidemiology of Candidemia in a Medical Center in Middle Taiwan","volume":"48","author":"Hii","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/6\/465\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:54:38Z","timestamp":1760032478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/6\/465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jof11060465"],"URL":"https:\/\/doi.org\/10.3390\/jof11060465","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]}}}